Anushka Irodi, Zhuoting Zhu, Andrzej Grzybowski, Yilan Wu, Carol Y. Cheung, Huating Li, Gavin Tan, Tien Yin Wong
{"title":"The evolution of diabetic retinopathy screening","authors":"Anushka Irodi, Zhuoting Zhu, Andrzej Grzybowski, Yilan Wu, Carol Y. Cheung, Huating Li, Gavin Tan, Tien Yin Wong","doi":"10.1038/s41433-025-03633-4","DOIUrl":null,"url":null,"abstract":"Diabetic retinopathy (DR) is a leading cause of preventable blindness and has emerged as a global health challenge, necessitating the development of robust management strategies. As DR prevalence continues to rise, advancements in screening methods have become increasingly critical for timely detection and intervention. This review examines three key advancements in DR screening: a shift from specialist to generalist approach, the adoption of telemedicine strategies for expanded access and enhanced efficiency, and the integration of artificial intelligence (AI). In particular, AI offers unprecedented benefits in the form of sustainability and scalability for not only DR screening but other aspects of eye health and the medical field as a whole. Though there remain barriers to address, AI holds vast potential for reshaping DR screening and significantly improving patient outcomes globally.","PeriodicalId":12125,"journal":{"name":"Eye","volume":"39 6","pages":"1040-1046"},"PeriodicalIF":3.2000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41433-025-03633-4.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41433-025-03633-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Diabetic retinopathy (DR) is a leading cause of preventable blindness and has emerged as a global health challenge, necessitating the development of robust management strategies. As DR prevalence continues to rise, advancements in screening methods have become increasingly critical for timely detection and intervention. This review examines three key advancements in DR screening: a shift from specialist to generalist approach, the adoption of telemedicine strategies for expanded access and enhanced efficiency, and the integration of artificial intelligence (AI). In particular, AI offers unprecedented benefits in the form of sustainability and scalability for not only DR screening but other aspects of eye health and the medical field as a whole. Though there remain barriers to address, AI holds vast potential for reshaping DR screening and significantly improving patient outcomes globally.
期刊介绍：
Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising clinician, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye is the official journal of The Royal College of Ophthalmologists.
Eye encourages the submission of original articles covering all aspects of ophthalmology including: external eye disease; oculo-plastic surgery; orbital and lacrimal disease; ocular surface and corneal disorders; paediatric ophthalmology and strabismus; glaucoma; medical and surgical retina; neuro-ophthalmology; cataract and refractive surgery; ocular oncology; ophthalmic pathology; ophthalmic genetics.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
